FullStem
Automated cell culture device revolutionizing regenerative therapies with applications in biocompatible fabrics, exosomes, cosmetics, and cultured meat.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
Fullstem.jp is at the forefront of biotechnology innovation, specializing in automated cell culture devices designed for regenerative therapies. Their flagship product, Achieva CS, offers a cost-effective solution for a wide range of applications including biocompatible fabrics, exosomes, cosmetics, cultured meat, and cell inks for bio 3D printers. The device simplifies the complex process of stem cell culture, making it accessible for diverse uses. Fullstem.jp primarily serves biotech companies, research institutions, and healthcare providers operating in the regenerative medicine market. The company's business model revolves around the sale and distribution of their proprietary cell culture devices, generating revenue through direct sales and potential licensing agreements.
Keywords: automated cell culture, regenerative therapies, biocompatible fabrics, exosomes, cosmetics, cultured meat, bio 3D printers, stem cells, biotechnology, healthcare.